Drug · DIN 02491087
EMGALITY
PREFILLED PEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 2, 2019; first marketed October 2, 2019.
- Drug Identification Number (DIN)
- 02491087
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Galcanezumab N02CD02
- Class
- Human
- Record last updated
- August 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GALCANEZUMAB | 120 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 30, 2019: NOC 22485New Drug Submission (NDS)
Other DINs named EMGALITY
- DIN 02491060 · Marketed
- DIN 02505134 · Marketed